{"DataElement":{"publicId":"2646314","version":"1","preferredName":"Kaposi Sarcoma Malignant Neoplasm Disease Marker Anatomic Location Specify","preferredDefinition":"the free text field to specify the other anatomic location of a malignant neoplasm disease marker of Kaposi Sarcoma.","longName":"KS_MN_DM_A_LCTN_SPEC","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2640038","version":"1","preferredName":"Kaposi Sarcoma Malignant Neoplasm Disease Marker Anatomic Location","preferredDefinition":"information relating to the position or site on the body where a disease marker (specific characteristics that may simplify the diagnostic process or help track disease progression) malignant neoplasm of Kaposi Sarcoma (a malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells) is present.","longName":"KS_MN_DM_ANATLCT","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2640017","version":"1","preferredName":"Kaposi Sarcoma Malignant Neoplasm","preferredDefinition":"A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin however, it may also occur internally.  It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS).:A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","longName":"C9087:C9305","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Kaposi Sarcoma","conceptCode":"C9087","definition":"A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin; however it may also occur internally. It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"30FA69F5-9B59-3F85-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-21","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-05-21","modifiedBy":"ONEDATA","dateModified":"2007-05-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2640036","version":"1","preferredName":"Disease Marker Anatomic Location","preferredDefinition":"Specific molecular signature of disease, physiological measurement, genotype structural or functional characteristic, metabolic changes, or other determinant that may simplify the diagnostic process, make diagnoses more accurate, distinguish different causes of disease, or enable physicians to make diagnoses before symptoms appear and to track disease progression.:Relating to anatomy.:A position, site, or point in space where something can be found.","longName":"C18329:C25421:C25341","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease Marker","conceptCode":"C18329","definition":"Specific molecular signature of disease, physiological measurement, genotype structural or functional characteristic, metabolic changes, or other determinant that may simplify the diagnostic process, make diagnoses more accurate, distinguish different causes of disease, or enable physicians to make diagnoses before symptoms appear and to track disease progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Anatomic","conceptCode":"C25421","definition":"Relating to anatomy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Location","conceptCode":"C25341","definition":"A position, site, or point in space where something can be found.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"30FB6718-3A6F-50EE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-21","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-05-21","modifiedBy":"ONEDATA","dateModified":"2007-05-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008526","version":"1","preferredName":"Anatomic Sites","preferredDefinition":"locations or structures in the human body.","longName":"ANAT_SITES","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1ED0F8B-4D91-332D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"30FB6718-3A80-50EE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-05-21","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2226669","version":"1","preferredName":"Anatomic Site Specify","preferredDefinition":"the free text field to specify an anatomic site.","longName":"ANATSITE_SPEC","context":"CTEP","contextVersion":"2.31","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008526","version":"1","preferredName":"Anatomic Sites","preferredDefinition":"locations or structures in the human body.","longName":"ANAT_SITES","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1ED0F8B-4D91-332D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184338","version":"1","preferredName":"Specify","preferredDefinition":"Specify; be specific about something; define clearly.","longName":"Specify","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-2084-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F600421C-68BC-0246-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-09","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-05-09","modifiedBy":"CAMPBELB","dateModified":"2008-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"7283431","version":"1","longName":"CRF CDEs","context":"AMC","ClassificationSchemeItems":[{"publicId":"7312662","version":"1","longName":"KS","context":"AMC"}]}],"AlternateNames":[{"name":"TULOCDTL5","type":"OID, AMC","context":"AMC"},{"name":"TULOCDTL4","type":"OID, AMC","context":"AMC"},{"name":"TULOCDTL2","type":"OID, AMC","context":"AMC"},{"name":"AMC","type":"USED_BY","context":"AMC"},{"name":"TULOCDTL1","type":"OID, AMC","context":"AMC"},{"name":"TULOCDTL3","type":"OID, AMC","context":"AMC"}],"ReferenceDocuments":[{"name":"Specify","type":"Preferred Question Text","description":"Specify","url":null,"context":"CTEP"},{"name":"AMC Question Text","type":"Alternate Question Text","description":"Specify Location","url":null,"context":"AMC"}],"origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"31DB3531-E22A-526E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-01","endDate":null,"createdBy":"SHIDED","dateCreated":"2007-06-01","modifiedBy":"COLLIED","dateModified":"2020-07-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}